GLP-1 medications have exploded in popularity over the past few years, and it\u2019s easy to see why. They work. People lose significant weight, blood sugar improves, and for the first time in a long time, weight management feels achievable. But anytime a drug goes from niche diabetes treatment to cultural phenomenon in the span of a couple years, it\u2019s worth stepping back and asking: how safe are these, really?<\/p>\n
The short answer is that GLP-1s have a strong safety track record based on what we know so far. But \u201cso far\u201d is doing some heavy lifting in that sentence.<\/p>\n
GLP-1 drugs aren\u2019t brand new. Earlier versions like Victoza and Byetta have been used for type 2 diabetes since the mid-2000s. The newer, longer-acting versions like Ozempic and Wegovy were approved more recently (Ozempic in 2017, Wegovy in 2021), but they\u2019ve been studied in large clinical trials involving thousands of patients over several years.<\/p>\n
Those trials showed that the most common side effects are gastrointestinal: nausea, vomiting, diarrhea, constipation. Most of these are mild to moderate and improve over time. Serious adverse events were relatively rare, but they did happen. Pancreatitis showed up in a small number of patients, and gallbladder issues, including gallstones, were more common in people losing weight rapidly. There were also cases of worsening diabetic retinopathy in people with existing eye disease.<\/p>\n
The trials also looked at cardiovascular outcomes, and the results were actually encouraging. GLP-1s reduced the risk of heart attack and stroke in people with diabetes and existing heart disease. That\u2019s a big deal, because cardiovascular disease is one of the leading causes of death in people with obesity and diabetes.<\/p>\n
The big caveat is that these trials followed people for a few years at most. We don\u2019t have decades of data on what happens when someone takes a GLP-1 for ten or twenty years. We don\u2019t know if there are long-term effects on the pancreas, thyroid, or other organs that only show up after prolonged use.<\/p>\n
There\u2019s also a thyroid cancer concern that comes up. In animal studies, GLP-1s caused thyroid tumors in rodents. This hasn\u2019t been seen in humans so far, but it\u2019s why these medications come with a warning about medullary thyroid carcinoma and why people with a personal or family history of this rare cancer shouldn\u2019t take them.<\/p>\n
Another unknown is what happens when large numbers of people use these drugs in the real world, outside the controlled environment of a clinical trial. We\u2019re already seeing reports of complications that weren\u2019t as obvious in trials, like severe gastroparesis (stomach paralysis), or aspiration during anesthesia because food stays in the stomach longer than expected.<\/p>\n
The FDA and drug manufacturers are actively monitoring for these issues, but real-world data takes time to accumulate. This is normal for any medication, but it\u2019s worth being aware of.<\/p>\n
Certain people are not good candidates for these medications. If you\u2019re pregnant or trying to get pregnant, GLP-1s are off the table. Animal studies showed potential harm to developing fetuses, and there\u2019s not enough human data to know if they\u2019re safe during pregnancy. If you\u2019re on a GLP-1 and want to get pregnant, you\u2019ll need to stop the medication at least two months before trying to conceive.<\/p>\n
Breastfeeding is also a no-go. We don\u2019t know if GLP-1s pass into breast milk or what effect they might have on a nursing infant, so the recommendation is to avoid them while breastfeeding.<\/p>\n
If you have a history of pancreatitis, medullary thyroid cancer, or multiple endocrine neoplasia syndrome type 2 (a genetic condition), GLP-1s aren\u2019t for you. If you have severe gastroparesis or digestion issues, these drugs could make things worse.<\/p>\n
Additionally, people with a history of eating disorders should approach GLP-1s cautiously. The appetite suppression can be intense, and for someone with a complicated relationship with food, that can be problematic.<\/p>\n
GLP-1 drugs are generally safe for most people when used as prescribed and monitored by a doctor. The benefits (significant weight loss, better blood sugar control, reduced cardiovascular risk) are real and well-documented. But they\u2019re not risk-free, and we\u2019re still learning about long-term effects.<\/p>\n
If you\u2019re considering a GLP-1, the key is going in with your eyes open. Talk to your doctor about your medical history, understand the known risks, and recognize that we\u2019re still in relatively early days for some of these medications. That doesn\u2019t mean they\u2019re unsafe \u2013 it just means that like any medical decision, it\u2019s about weighing what we know against what we don\u2019t, and deciding what makes sense for you.<\/p>\n
This column does not establish a provider\/patient relationship and is for general informational purposes only. This column is not a substitute for consulting with a physician or other health care provider.<\/p>\n
\t \t \t \t=htmlentities(get_the_title())?>%0D%0A%0D%0A=get_permalink()?>%0D%0A%0D%0A=htmlentities(‘For more stories like this one, be sure to visit https:\/\/www.eastidahonews.com\/ for all of the latest news, community events and more.’)?>&subject=Check%20out%20this%20story%20from%20EastIdahoNews” class=”fa-stack jDialog”> \t <\/p>\n","protected":false},"excerpt":{"rendered":"GLP-1 medications have exploded in popularity over the past few years, and it\u2019s easy to see why. They…\n","protected":false},"author":2,"featured_media":681954,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[64,63,137,490],"class_list":["post-681953","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-au","tag-australia","tag-health","tag-medication"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/681953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=681953"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/681953\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/681954"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=681953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=681953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=681953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}